The popular weightloss pill Reductil (made by Abbott Laboratories and also called sibutramine) has been banned in Europe and is under review here in Australia following new evidence that it may increase the risk of heart attack in people with cardiovascular disease. The Australian regulatory authority, the TGA, has received over 200 reports of adverse reactions to Reductil since its introduction into the Australian market, including possible links to the death of a 19 year old patient.
Click here for the full story
